Bifidobacterium Lactobacillus Triple Viable Alleviates Slow Transit Constipation by Regulating Gut Microbiota and Metabolism
Journal of Gastroenterology and Hepatology · 2025-06 · 40 (6) · 1561-1573
DOI: 10.1111/jgh.16960 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 04.04.2025. Verfasst von Mei Luo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Constipation, Gastrointestinal Microbiome, Gastrointestinal Transit, Bifidobacterium. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: GuangDong Basic and Applied Basic Research Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Gut microbiota plays a crucial role in the pathogenesis and treatment of functional constipation (FC). The aim of this study was to explore the therapeutic effects of Bifidobacterium Lactobacillus triple viable on slow transit constipation (STC).
Methods
Patients with STC who met the Rome IV criteria received Bifidobacterium Lactobacillus triple viable. Gastrointestinal transit time (GITT) and constipation‐related symptoms were assessed before and after receiving Bifidobacterium Lactobacillus triple viable. Additionally, a rat STC model was induced by loperamide and was treated with Bifidobacterium Lactobacillus triple viable to evaluate whether Bifidobacterium Lactobacillus triple viable could improve constipation in the rats and to explore the possible mechanisms involved.
Results
In patients with STC, Bifidobacterium Lactobacillus triple viable accelerated GITT and improved constipation‐related symptoms, including bowel movement frequency, hard bowel movement, incomplete defecation, defecation time, purgative measures, and stool form. In addition, Bifidobacterium Lactobacillus triple viable improved body weight, food intake, bowel movement, the fecal water content, and the intestinal propulsion rate in STC rats. It regulates the gut microbiota structure in rats; increases serum acetylcholine (Ach), 5‐hydroxytryptamine (5‐HT), substance P (SP), and vasoactive intestinal peptide (VIP); increases fecal long‐chain fatty acids (LCFAs); upregulates the mRNA expression of aquaporin 3 (AQP3) and aquaporin 3 (AQP8); and downregulates the mRNA expression of Toll‐like receptor 2 (TLR2), Toll‐like receptor 4 (TLR4), and interleukin‐1β (IL‐1β).
Conclusions
Bifidobacterium Lactobacillus triple viable ameliorated the GITT and constipation‐related symptoms of patients with STC and improved the STC in rats by regulating the gut microbiota and metabolism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
ORCID-Profile: Lishou Xiong
Förderung
- GuangDong Basic and Applied Basic Research Foundation
- National Natural Science Foundation of China
Zitieren
APA
Luo, M., Xie, P., Deng, X., Fan, J., & Xiong, L. (2025). Bifidobacterium Lactobacillus Triple Viable Alleviates Slow Transit Constipation by Regulating Gut Microbiota and Metabolism. Journal of Gastroenterology and Hepatology, 40(6), 1561-1573. https://doi.org/10.1111/jgh.16960
Vancouver
Luo M, Xie P, Deng X, Fan J, Xiong L. Bifidobacterium Lactobacillus Triple Viable Alleviates Slow Transit Constipation by Regulating Gut Microbiota and Metabolism. Journal of Gastroenterology and Hepatology. 2025;40(6):1561-1573. doi:10.1111/jgh.16960
BibTeX
@article{Luo2025,
author = {Luo, Mei and Xie, Peiwei and Deng, Xuehong and Fan, Jiahui and Xiong, Lishou},
title = {Bifidobacterium Lactobacillus Triple Viable Alleviates Slow Transit Constipation by Regulating Gut Microbiota and Metabolism},
journal = {Journal of Gastroenterology and Hepatology},
year = {2025},
volume = {40},
number = {6},
pages = {1561--1573},
doi = {10.1111/jgh.16960}
}
EUVIMED